<?xml version="1.0" encoding="UTF-8"?>
<ref id="B49-vaccines-08-00224">
 <label>49.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Channappanavar</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Fehr</surname>
    <given-names>A.R.</given-names>
   </name>
   <name>
    <surname>Zheng</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Wohlford-Lenane</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Abrahante</surname>
    <given-names>J.E.</given-names>
   </name>
   <name>
    <surname>Mack</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Sompallae</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>McCray</surname>
    <given-names>P.B.</given-names>
    <suffix>Jr.</suffix>
   </name>
   <name>
    <surname>Meyerholz</surname>
    <given-names>D.K.</given-names>
   </name>
   <name>
    <surname>Perlman</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes</article-title>
  <source>J. Clin. Investig.</source>
  <year>2019</year>
  <volume>130</volume>
  <fpage>3625</fpage>
  <lpage>3639</lpage>
  <pub-id pub-id-type="doi">10.1172/JCI126363</pub-id>
 </element-citation>
</ref>
